You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
明德生物(002932.SZ)擬投資3000萬元設立全資子公司
格隆匯 11-09 20:01

格隆匯11月9日丨明德生物(002932.SZ)公佈,公司投資設立全資子公司“湖北明德醫療科技有限責任公司”,註冊資本為3000萬元,公司將以自有資金出資,佔其全部股權的100%。

經營範圍:一類、二類和三類醫療器械銷售及租賃;普通實驗室試劑(不含危險爆炸化學品及國家限制經營的品種)、化學試劑(不含危險爆炸化學品及國家限制經營的品種)、塑料製品、通訊器材、通信設備(不含無線電發射設備)、電力設備、電子產品(不含電子出版物)、傳感器、辦公用品、實驗室儀器設備、五金交電、日用品的批發兼零售;儀器儀表(不含許可項)、計算機及軟硬件的銷售及安裝;計算機軟件技術的開發、技術轉讓、技術諮詢及技術服務;醫療器械技術諮詢、安裝、檢測、維修;企業管理應用軟件的銷售及售後服務(不含證券、期貨、保險、金融資產管理);健康諮詢(不含診療);技術進出口(國家禁止或涉及行政審批的貨物和技術進出口除外);實驗室工程、建築智能化工程、鋼結構工程、建築機電安裝工程施工;室內外裝飾裝修工程設計與施工;實驗室設備、線路、管道安裝工程施工(不含壓力管道)(涉及許可經營項目,應取得相關部門許可後方可經營)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account